Bone Marrow Stem Cell-Mediated Regeneration in IBD: Where Do We Go From Here?

Gastroenterology

Volumn 132, Issue 3, 2007, Pages 1171-1173

  Brittan, Mairi ^a   Alison, Malcolm R ^a   Schier, Stephanie ^b   Wright, Nicholas A ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; CELL KINETICS; CELL POPULATION; CELL REGENERATION; CELL THERAPY; EDITORIAL; ENTERITIS; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 33947304185     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.01.064     Document Type: Editorial

References (26)

1. Khalil P.N., Weiler V., Nelson P.J., Khalil M.N., Moosmann S., Mutschler W.E., Siebeck M., and Huss R. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 132 (2007) 944-954
2. Leung Y., Geddes M., Storek J., Panaccione R., and Beck P.L. Hematopoietic cell transplantation for Crohn's disease; is it time?. World J Gastroenterol 12 (2006) 6665-6673
3. Ditschkowski M., Einsele H., Schwerdtfeger R., Bunjes D., Trenschel R., Beelen D.W., and Elmaagacli A.H. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation 75 (2003) 1745-1747
4. Lopez-Cubero S.O., Sullivan K.M., and McDonald G.B. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 114 (1998) 433-440
5. Talbot D.C., Montes A., Teh W.L., Nandi A., and Powles R.L. Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia. Hosp Med 59 (1998) 580-581
6. Castro J., Bentch H., Smith L., Kalter S., Bachier C., Meneghetti C., Moore A., Oliversen S., and LeMaistre C. Prolonged clinical remission in patients with inflammatory bowel disease (IBD) after high dose chemotherapy (HDC) and autologous blood stem cell transplantation (ABSCT). Blood 88 (1996)
7. Drakos P.E., Nagler A., and Or R. Case of Crohn's disease in bone marrow transplantation. Am J Hematol 43 (1993) 157-158
8. Kashyap A., and Forman S.J. Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease. Br J Haematol 103 (1998) 651-652
9. Oyama Y., Craig R.M., Traynor A.E., Quigley K., Statkute L., Halverson A., Brush M., Verda L., Kowalska B., Krosnjar N., Kletzel M., Whitington P.F., and Burt R.K. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 128 (2005) 552-563
10. Soderholm J.D., Malm C., Juliusson G., and Sjodahl R. Long-term endoscopic remission of Crohn's disease after autologous stem cell transplantation for acute myeloid leukaemia. Scand J Gastroenterol 37 (2002) 613-616
11. Bonen D.K., and Cho J.H. The genetics of inflammatory bowel disease. Gastroenterology 124 (2003) 521-536
12. Baron F.A., Hermanne J.P., Dowlati A., Weber T., Thiry A., Fassotte M.F., Fillet G., and Beguin Y. Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 21 (1998) 951-954
13. Sonwalkar S.A., James R.M., Ahmad T., Zhang L., Verbeke C.S., Barnard D.L., Jewell D.P., and Hull M.A. Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut 52 (2003) 1518-1521
14. Komori M., Tsuji S., Tsujii M., Murata H., Iijima H., Yasumaru M., Nishida T., Irie T., Kawano S., and Hori M. Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Repair Regen 13 (2005) 109-118
15. Brittan M., Chance V., Elia G., Poulsom R., Alison M.R., Macdonald T.T., and Wright N.A. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology 128 (2005) 1984-1995
16. Direkze N.C., Jeffery R., Hodivala-Dilke K., Hunt T., Playford R.J., Elia G., Poulsom R., Wright N.A., and Alison M.R. Bone marrow-derived stromal cells express lineage-related messenger RNA species. Cancer Res 66 (2006) 1265-1269
17. Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., Ito K., Koh G.Y., and Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
18. De Palma M., Venneri M.A., Galli R., Sergi Sergi L., Politi L.S., Sampaolesi M., and Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8 (2005) 211-226
19. Sato A., Iwama A., Takakura N., Nishio H., Yancopoulos G.D., and Suda T. Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int Immunol 10 (1998) 1217-1227
20. Yokota T., Huang J., Tavian M., Nagai Y., Hirose J., Zuniga-Pflucker J.C., Peault B., and Kincade P.W. Tracing the first waves of lymphopoiesis in mice. Development 133 (2006) 2041-2051
21. Zengin E., Chalajour F., Gehling U.M., Ito W.D., Treede H., Lauke H., Weil J., Reichenspurner H., Kilic N., and Ergun S. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133 (2006) 1543-1551
22. Huss R., Hong D.S., McSweeney P.A., Hoy C.A., and Deeg H.J. Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor. Proc Natl Acad Sci U S A 92 (1995) 748-752
23. + stem cell line. J Hematother Stem Cell Res 8 (1999) 335-342
24. Pipas J.M., and Levine A.J. Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol 11 (2001) 23-30
25. Voorhoeve P.M., and Agami R. Unraveling human tumor suppressor pathways: a tale of the INK4A locus. Cell Cycle 3 (2004) 616-620
26. Taupin P. OTI-010 Osiris therapeutics/JCR pharmaceuticals. Curr Opin Investig Drugs 7 (2006) 473-481